Last Updated:
NameDesignationAppointment DateStatus
Biswanath Paul

Appointed as Director since April 2018

Director02-Apr-2018Current
Kalpana Chakraborty

Appointed as Director since March 2005

Director01-Mar-2005Current
Probhas Bondhu Chakraborty

Appointed as Director since December 2004

Director10-Dec-2004Current
Pulak Ranjan Nag

Appointed as Director since February 2022

Director01-Feb-2022Current
Srijani Swapankumar Lahiri

Appointed as Director since January 2022

Director25-Jan-2022Current
Premium access

Complete director details

Unlock the complete director and KMP records available for Mendine Pharmaceuticals Pvt Ltd.

  • Complete appointment and designation records
  • Current and past company associations
  • Shareholding and remuneration where filed

Verified entity values are shown only after access is granted.

People Timeline

Explore the timeline of key personnel in Mendine Pharmaceuticals Pvt Ltd's leadership journey.

Loading...
Contact Details
  • Address 36-A& B Alipore Rd, Kolkata West Bengal, 700027, India
  • Telephone Upgrade
  • Email Upgrade
Frequently Asked Questions
You can contact Mendine Pharmaceuticals Pvt Ltd through their registered address at 36-A& B Alipore Rd, Kolkata West Bengal, 700027, India, or via their website at mendine.com. Social media links are also provided where applicable.
The current directors of Mendine Pharmaceuticals Pvt Ltd are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • PROBHAS BONDHU CHAKRABORTY
  • KALPANA CHAKRABORTY
  • PULAK RANJAN NAG
  • SRIJANI SWAPANKUMAR LAHIRI
  • BISWANATH PAUL
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available